Arnie- is that the same ugly car? These Hennessy guys have five SPACS!!! Can they really have their eye on the ball.. How have the other 4 done? This Vid is from when they had 4 before the car that looks the same driving forwards and backwards. And you know if they would put a steering wheel on both sides I'd be into it! Like a train that cannot turn around sometimes you wish you just climb in the backseat and drive the other direction out. Happens in parking lots. This is the guy in charge and I do make snap judgement based off looks I know I shouldn't... But this guy looks like he drinks. And with a name of Hennessy, one wonders...
Possible stock for Van's Vietnam Fund For Granny>>>> Company Profile Chindata Group Holdings Limited provides carrier-neutral hyper scale data center solutions in China, India, and Southeast Asia markets. It offers colocation and managed, energy procurement and transmission, infrastructure, and IT and network services. The company was formerly known as BCPE Bridge Stack Limited and changed its name to Chindata Group Holdings Limited in April 2020. Chindata Group Holdings Limited was founded in 2015 and is headquartered in Beijing, China. Now I don't know about Chinese stocks but I lie the name change. Chindata initiated with a Buy at UBS 08:38 CD UBS initiated coverage of… Story temporarily locked.--> let's do this!!!-> Data centers in China... ahhhh Yes please! Unusually Large Price target Changes-) ) ) --Alnylam price target raised to $181 from $169 at Piper Sandler » Stk @$138 --Aptiv price target raised to $145 from $112 at Barclays » This one is interesting in that they have a connection to driverless cars... looks a bit like a cult. stk@$123
This looks covid related!!! CohBar announces preclinical data on apelin agonist peptides 12/09 CWBR CohBar announced new preclinical data confirming the efficacy of its apelin agonist peptides in a preclinical model of acute respiratory distress syndrome. The company expects the apelin agonists to have potential to treat COVID-19 associated ARDS as well as ARDS patients in general, of which there are approximately three million globally. In the preclinical study, acute lung injury was induced in mice by administration of lipopolysaccharide, a bacterial toxin that produces similar symptoms to other causes of ARDS, including fluid accumulation and cytokine secretion. A single dose of CB5064 Analog was administered one hour prior to the LPS exposure and effects on lung weight and levels of pro-inflammatory cytokines were measured at 4 hours after LPS exposure. Treatment with CB5064 Analogs reduced fluid accumulation in the lungs and a corresponding broad reduction in levels of key pro-inflammatory cytokines secreted into the lung fluid, when compared to treatment with a placebo control.
ruh roe I might of found something.... I can't get into that new PT it's locked but i found an old One and LOOKK!!!! CohBar initiated with a Speculative Buy at WBB Securities 10/15 CWBR WBB Securities analyst Steve Brozak initiated coverage of CohBar with a Speculative Buy rating and $4.50 price target. The company is developing Mitochondrial Based Therapies, which is an emerging class of drugs, and has 12 issued patents as well as over 65 patent applications filed, noted Brozak. Oh my--- I think the stk is EXACTLY $1 WE CAN TALK ABOUT IT!!! QUICK COHBAR IS THE GUMMY OF THE DAY!!!!-- I'M GOING TO DO IT!--
REMEMBER YESTERDAY WE HAD THE BIO AND IT WAS FLAT AND WE GOT STONED AND THEN BOUGHT IT UP $1 LETS NOT SCREW THIS ONE UP KIDDO!!!!//
place to buy is $1.37 who's with me!! Unconventional... ??? 1.4400 +0.15 (11.63%)<----- Shhhhhhhhhhh. We can't let Robin Hod know about this until later in the day..... Before hours: 9:11AM EST
Chindata initiated with a Buy at Citi 11/23 CD Citi analyst Arthur Lai initiated coverage of Chindata Group Holdings with a Buy rating and $20 price target. The analyst expects the company achieve "strong" revenue and EBITDA growth driven by structural demand for data infrastructure. Lai believes EBITDA growth will be the share price driver in the long term. I'm kind of liking this the PT's are right around the stock price $2 above don't love that but like the general idea alot...